267 related articles for article (PubMed ID: 21818286)
21. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.
Jin Z; Wang L; Zhang Y; Cheng Y; Gao Y; Feng X; Dong M; Cao Z; Chen S; Yu H; Zhao Z; Zhang X; Liu J; Mori Y; Fan X; Meltzer SJ
Sci Rep; 2013 Oct; 3():2838. PubMed ID: 24088706
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
23. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
24. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.
Sanders YY; Liu H; Scruggs AM; Duncan SR; Huang SK; Thannickal VJ
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):50-61. PubMed ID: 27560128
[TBL] [Abstract][Full Text] [Related]
26. Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma.
Mizuno Y; Maemura K; Tanaka Y; Hirata A; Futaki S; Hamamoto H; Taniguchi K; Hayashi M; Uchiyama K; Shibata MA; Otsuki Y; Kondo Y
Oncol Rep; 2018 May; 39(5):2209-2216. PubMed ID: 29512761
[TBL] [Abstract][Full Text] [Related]
27. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
28. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
Jin Z; Mori Y; Yang J; Sato F; Ito T; Cheng Y; Paun B; Hamilton JP; Kan T; Olaru A; David S; Agarwal R; Abraham JM; Beer D; Montgomery E; Meltzer SJ
Oncogene; 2007 Sep; 26(43):6332-40. PubMed ID: 17452981
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
Sanders YY; Tollefsbol TO; Varisco BM; Hagood JS
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):16-23. PubMed ID: 20724553
[TBL] [Abstract][Full Text] [Related]
33. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
Sheyhidin I; Hasim A; Zheng F; Ma H
Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
36. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
Moon JW; Choi JH; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Kim GJ; Park SH
Cancer Genet; 2015 May; 208(5):261-70. PubMed ID: 26002729
[TBL] [Abstract][Full Text] [Related]
38. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma.
Corn PG; Heath EI; Heitmiller R; Fogt F; Forastiere AA; Herman JG; Wu TT
Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.
Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z
Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of the circadian clock: role of 5-aza-2'-deoxycytidine.
Tomita T; Kurita R; Onishi Y
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28487473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
